AP2964A - Powders for reconstitution - Google Patents

Powders for reconstitution

Info

Publication number: AP2964A
Authority: AP; ARIPO
Prior art keywords: reconstitution; powders
Prior art date: 2007-03-14

Application number

AP2009004969A

Other languages

English (en)

Other versions

AP2009004969A0 (en

Inventor

Lieven Elvire Colette Baert

Elke Van Gyseghem

Guy Rene Jaak Van Den Mooter

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-14

Filing date

2008-03-14

Publication date

2014-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38055251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2964(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-03-14 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2009-10-31 Publication of AP2009004969A0 publication Critical patent/AP2009004969A0/xx

2014-09-30 Application granted granted Critical

2014-09-30 Publication of AP2964A publication Critical patent/AP2964A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Compositions Of Macromolecular Compounds (AREA)

AP2009004969A 2007-03-14 2008-03-14 Powders for reconstitution AP2964A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07104082		2007-03-14
PCT/EP2008/053056 WO2008110619A1 (en)	2007-03-14	2008-03-14	Powders for reconstitution

Publications (2)

Publication Number	Publication Date
AP2009004969A0 AP2009004969A0 (en)	2009-10-31
AP2964A true AP2964A (en)	2014-09-30

Family

ID=38055251

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2009004969A AP2964A (en)	2007-03-14	2008-03-14	Powders for reconstitution

Country Status (18)

Country	Link
US (1)	US8916558B2 (es)
EP (1)	EP2043608B1 (es)
JP (1)	JP5554571B2 (es)
KR (1)	KR101580297B1 (es)
CN (1)	CN101636149B (es)
AP (1)	AP2964A (es)
AR (2)	AR065720A1 (es)
AU (1)	AU2008225774B2 (es)
BR (1)	BRPI0808897B8 (es)
CA (1)	CA2676981C (es)
CL (1)	CL2008000746A1 (es)
ES (1)	ES2535162T3 (es)
IL (1)	IL199874A (es)
MX (1)	MX2009009743A (es)
RU (1)	RU2477133C2 (es)
TW (1)	TWI494133B (es)
WO (1)	WO2008110619A1 (es)
ZA (1)	ZA200906344B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY169670A (en)	2003-09-03	2019-05-08	Tibotec Pharm Ltd	Combinations of a pyrimidine containing nnrti with rt inhibitors
AR065720A1 (es)	2007-03-14	2009-06-24	Tibotec Pharm Ltd	Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
HRP20201241T1 (hr) *	2011-04-15	2020-11-27	Janssen Pharmaceutica N.V.	Nanosuspenzije lijeka osušene zamrzavanjem
CN104684545B (zh) *	2012-09-27	2018-04-03	巴斯夫欧洲公司	包含至少一种水溶性维生素e衍生物和至少一种亲水聚合物的储存稳定的无粉尘均质颗粒状配制剂
CA3144534A1 (en) *	2019-07-03	2021-01-07	Janssen Sciences Ireland Unlimited Company	Methods of treating hiv in pediatric patients with rilpivirine
CN113440529B (zh) *	2020-03-25	2023-11-14	江苏恒瑞医药股份有限公司	一种可注射的药物组合物及其制备方法
CN114392241B (zh) *	2022-01-10	2023-07-25	安徽贝克生物制药有限公司	一种利匹韦林片及其制备方法
JP2025513501A (ja) *	2022-04-22	2025-04-24	ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー	凍結乾燥組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0489181A1 (en) *	1990-07-19	1992-06-10	Otsuka Pharmaceutical Co., Ltd.	Solid preparation
US5368864A (en) *	1988-11-25	1994-11-29	Henning Berlin Gmbh Chemie- Und Pharmawerk	Formulation of oxypurinol and/or its alkali and alkaline earth salts
WO2004050058A2 (en) *	2002-11-29	2004-06-17	Janssen Pharmaceutica N.V.	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2006108828A1 (en) *	2005-04-11	2006-10-19	Tibotec Pharmaceuticals Ltd.	(1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3089818A (en) *	1960-06-02	1963-05-14	Baxter Laboratories Inc	Water dispersible antibiotics
US5182111A (en) *	1987-11-17	1993-01-26	Boston University Research Foundation	In vivo delivery of active factors by co-cultured cell implants
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
AU3124793A (en) *	1991-10-29	1993-06-07	Clover Consolidated, Limited	Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
DK0639971T3 (da)	1992-05-13	2000-03-20	Wellcome Found	Terapeutiske kombinationer
JPH06316524A (ja)	1992-09-11	1994-11-15	Naoyuki Inoue	抗エイズウイルス剤
TW401303B (en)	1994-07-01	2000-08-11	Janssen Pharmaceutica Nv	Anti-HIV triple combination
US6045829A (en) *	1997-02-13	2000-04-04	Elan Pharma International Limited	Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
JP2003509453A (ja)	1999-09-21	2003-03-11	アールティーピー・ファーマ・インコーポレーテッド	生物学的に活性な物質の、表面改質された粒状組成物
WO2001022938A1 (en) *	1999-09-24	2001-04-05	Janssen Pharmaceutica N.V.	Antiviral compositions
US6743446B2 (en) *	1999-12-15	2004-06-01	The Ohio State University Research Foundation	Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers
TWI284048B (en) *	2000-01-27	2007-07-21	Zentaris Ag	Compressed microparticles for dry injection
HUP0302631A2 (hu)	2000-03-30	2003-11-28	Bristol-Myers Squibb Co.	Stavudint tartalmazó elnyújtott hatóanyag-kibocsátású szemcsék
US20040115268A1 (en) *	2000-04-26	2004-06-17	Control Delivery Systems, Inc.	Systemic delivery of antiviral agents
DE10050199A1 (de)	2000-10-11	2002-04-25	Ethicon Gmbh	Flächiges Implantat mit im Ultraschall detektierbaren Elementen
EP1350792A1 (en)	2000-12-11	2003-10-08	Takeda Chemical Industries, Ltd.	Medicinal compositions improved in solublity in water
CA2450957A1 (en) *	2001-06-22	2003-01-03	Pfizer Products Inc.	Pharmaceutical compositions of dispersions of drugs and neutral polymers
JO3429B1 (ar) *	2001-08-13	2019-10-20	Janssen Pharmaceutica Nv	مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en)	2003-09-03	2019-05-08	Tibotec Pharm Ltd	Combinations of a pyrimidine containing nnrti with rt inhibitors
AU2002364701B8 (en)	2001-11-20	2006-06-22	Alkermes, Inc.	Compositions for sustained action product delivery
ES2422196T3 (es)	2002-08-09	2013-09-09	Janssen Pharmaceutica Nv	Procesos para la preparación de 4-4-4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)aminobenzonitrilo
WO2004022033A1 (en) *	2002-09-04	2004-03-18	Microchips, Inc.	Method and device for the controlled delivery of parathyroid hormone
ATE361059T1 (de)	2002-11-08	2007-05-15	Glaxo Group Ltd	Antivirale zusammensetzungen
KR20050084621A (ko)	2002-11-15	2005-08-26	티보텍 파마슈티칼즈 리미티드	항감염성 화합물로서의 치환된 인돌피리디늄
CL2004000192A1 (es)	2003-02-07	2005-03-18	Janssen Pharmaceutica Nv	Uso de compuestos derivados de 2-aminopirimidina para preparar un medicamento para la prevencion de una infeccion por vih relaciones sexuales o un contacto intimo en la pareja.
KR100629771B1 (ko) *	2004-01-27	2006-09-28	씨제이 주식회사	결정성이 감소되거나 무정형화된 올티프라즈의 제조방법
BRPI0511900A (pt) *	2004-06-08	2008-01-22	Vertex Pharma	composições farmacêuticas
MY191349A (en)	2004-08-27	2022-06-17	Bayer Pharmaceuticals Corp	New pharmaceutical compositions for the treatment of hyper-proliferative disorders
SI1632232T1 (sl)	2004-09-02	2011-09-30	Janssen Pharmaceutica Nv	Sol 4((4((4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)amino) benzonitrila
PL1632232T6 (pl)	2004-09-02	2022-06-27	Janssen Pharmaceutica Nv	Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu
ES2526092T3 (es)	2004-11-16	2015-01-05	Alkermes Pharma Ireland Limited	Formulaciones de olanzapina en nanopartículas inyectables
TWI457136B (zh)	2005-04-04	2014-10-21	Tibotec Pharm Ltd	Ｈｉｖ-感染之預防
WO2006110889A2 (en) *	2005-04-11	2006-10-19	The Board Of Trustees Of The Leland Stanford Junior University	Multi-layer structure having a predetermined layer pattern including an agent
US20090142401A1 (en)	2005-06-07	2009-06-04	Leah Elizabeth Appel	Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
US20070026073A1 (en)	2005-07-28	2007-02-01	Doney John A	Amorphous efavirenz and the production thereof
RS52821B2 (sr)	2006-01-20	2021-07-30	Janssen Sciences Ireland Unlimited Co	Dugotrajno tretiranje hiv-infekcije sa tcm278
ES2372983T3 (es)	2006-06-06	2012-01-30	Tibotec Pharmaceuticals	Proceso para preparar formulaciones secadas por aspersión de tmc125.
HUE038797T2 (hu)	2006-06-23	2018-11-28	Janssen Sciences Ireland Uc	TMC278 vizes szuszpenziói
WO2008060360A2 (en) *	2006-09-28	2008-05-22	Surmodics, Inc.	Implantable medical device with apertures for delivery of bioactive agents
AR065720A1 (es)	2007-03-14	2009-06-24	Tibotec Pharm Ltd	Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
ES2437331T3 (es)	2007-07-12	2014-01-10	Janssen R&D Ireland	Forma cristalina de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrilo
WO2009046299A2 (en)	2007-10-04	2009-04-09	Boston Scientific Scimed, Inc	Implantable drug depot for intrathecal drug delivery system for pain management
WO2010047819A1 (en) *	2008-10-24	2010-04-29	Concert Pharmaceuticals, Inc.	Hydroxyethylamino sulfonamide derivatives

2008
- 2008-03-13 AR ARP080101032A patent/AR065720A1/es not_active Application Discontinuation
- 2008-03-13 TW TW097108780A patent/TWI494133B/zh active
- 2008-03-13 CL CL200800746A patent/CL2008000746A1/es unknown
- 2008-03-14 WO PCT/EP2008/053056 patent/WO2008110619A1/en not_active Ceased
- 2008-03-14 MX MX2009009743A patent/MX2009009743A/es active IP Right Grant
- 2008-03-14 CN CN200880008342.0A patent/CN101636149B/zh active Active
- 2008-03-14 JP JP2009553156A patent/JP5554571B2/ja active Active
- 2008-03-14 BR BRPI0808897A patent/BRPI0808897B8/pt not_active IP Right Cessation
- 2008-03-14 KR KR1020097017592A patent/KR101580297B1/ko not_active Expired - Fee Related
- 2008-03-14 AP AP2009004969A patent/AP2964A/xx active
- 2008-03-14 US US12/530,665 patent/US8916558B2/en active Active
- 2008-03-14 ES ES08717800.0T patent/ES2535162T3/es active Active
- 2008-03-14 CA CA2676981A patent/CA2676981C/en active Active
- 2008-03-14 AU AU2008225774A patent/AU2008225774B2/en not_active Ceased
- 2008-03-14 RU RU2009137911/15A patent/RU2477133C2/ru active
- 2008-03-14 EP EP08717800.0A patent/EP2043608B1/en active Active
2009
- 2009-07-15 IL IL199874A patent/IL199874A/en active IP Right Grant
- 2009-09-11 ZA ZA2009/06344A patent/ZA200906344B/en unknown
2019
- 2019-01-21 AR ARP190100128A patent/AR114086A2/es not_active Application Discontinuation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5368864A (en) *	1988-11-25	1994-11-29	Henning Berlin Gmbh Chemie- Und Pharmawerk	Formulation of oxypurinol and/or its alkali and alkaline earth salts
EP0489181A1 (en) *	1990-07-19	1992-06-10	Otsuka Pharmaceutical Co., Ltd.	Solid preparation
WO2004050058A2 (en) *	2002-11-29	2004-06-17	Janssen Pharmaceutica N.V.	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2006108828A1 (en) *	2005-04-11	2006-10-19	Tibotec Pharmaceuticals Ltd.	(1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as hiv viral repliation inhibitors

Also Published As

Publication number	Publication date
CN101636149A (zh)	2010-01-27
IL199874A0 (en)	2010-04-15
AR065720A1 (es)	2009-06-24
EP2043608A1 (en)	2009-04-08
BRPI0808897A2 (pt)	2014-09-02
CL2008000746A1 (es)	2008-09-22
JP5554571B2 (ja)	2014-07-23
US20100120795A1 (en)	2010-05-13
ES2535162T3 (es)	2015-05-05
CN101636149B (zh)	2014-08-06
IL199874A (en)	2016-02-29
US8916558B2 (en)	2014-12-23
BRPI0808897B8 (pt)	2021-05-25
CA2676981C (en)	2015-01-13
AP2009004969A0 (en)	2009-10-31
WO2008110619A1 (en)	2008-09-18
EP2043608B1 (en)	2015-01-21
KR101580297B1 (ko)	2015-12-24
AR114086A2 (es)	2020-07-22
JP2010520918A (ja)	2010-06-17
RU2477133C2 (ru)	2013-03-10
TW200911303A (en)	2009-03-16
RU2009137911A (ru)	2011-04-20
KR20090119964A (ko)	2009-11-23
BRPI0808897B1 (pt)	2020-10-20
AU2008225774A1 (en)	2008-09-18
ZA200906344B (en)	2015-04-29
TWI494133B (zh)	2015-08-01
CA2676981A1 (en)	2008-09-18
MX2009009743A (es)	2009-09-23
AU2008225774B2 (en)	2014-04-10

Publication	Publication Date	Title
DK200800103A (en)	2008-07-30	Integreret føringskant for vindturbineblad
GB0712764D0 (en)	2007-08-08	Carrying Bag
AU319129S (en)	2008-05-09	Container
AU319092S (en)	2008-05-05	Container
GB0716441D0 (en)	2007-10-03	Powders
AU319130S (en)	2008-05-09	Container
IL190589A0 (en)	2008-12-29	Level-restorer supply-regulated pll
ZA200905738B (en)	2010-05-26	Iron-hydrocarbon complex compounds
ZA200906344B (en)	2015-04-29	Powders for reconstitution
GB0708567D0 (en)	2007-06-13	Imaging technique
GB0700361D0 (en)	2007-02-14	Pack
AU319091S (en)	2008-05-05	Container
GB2455650B (en)	2010-05-19	Vaccines for brucellosis
GB0715132D0 (en)	2007-09-12	Tissue-adhesive materials
ZA200908588B (en)	2011-02-23	Pack
EP2130702A4 (en)	2015-04-29	MODE OF TRANSPORT
GB0713587D0 (en)	2007-08-22	Insulaitng materials
GB0704646D0 (en)	2007-04-18	Improved container
GB2447456B (en)	2008-11-26	Single-shoulder bag
GB0707047D0 (en)	2007-05-23	Bag
GB0708729D0 (en)	2007-06-13	Booska pod bag
PH32007000341S1 (en)	2007-07-09	Powder case
GB0725328D0 (en)	2008-02-06	Data-handleing means
AU315653S (en)	2007-08-14	Bag
AU315652S (en)	2007-08-14	Bag